Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma

A. Younes, F. Wong

Research output: Contribution to journalComment/debatepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma'. Together they form a unique fingerprint.